Your browser doesn't support javascript.
loading
Amplified antitumor efficacy by a targeted drug retention and chemosensitization strategy-based "combo" nanoagent together with PD-L1 blockade in reversing multidrug resistance.
Jiang, Weixi; Su, Lei; Ao, Meng; Guo, Xun; Cheng, Chen; Luo, Yuanli; Xie, Zhuoyan; Wang, Xingyue; Wang, Junrui; Liu, Shuling; Cao, Yang; Li, Pan; Wang, Zhigang; Ran, Haitao; Zhou, Zhiyi; Ren, Jianli.
Afiliação
  • Jiang W; Department of Ultrasound, Chongqing Key Laboratory of Ultrasound Molecular Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China.
  • Su L; Department of Ultrasound, Chongqing Key Laboratory of Ultrasound Molecular Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China.
  • Ao M; Department of Ultrasound, Chongqing Key Laboratory of Ultrasound Molecular Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China.
  • Guo X; Department of Ultrasound, Chongqing Key Laboratory of Ultrasound Molecular Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China.
  • Cheng C; Department of Ultrasound, Chongqing Key Laboratory of Ultrasound Molecular Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China.
  • Luo Y; Department of Ultrasound, Chongqing Key Laboratory of Ultrasound Molecular Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China.
  • Xie Z; Department of Ultrasound, Chongqing Key Laboratory of Ultrasound Molecular Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China.
  • Wang X; Department of Ultrasound, Chongqing Key Laboratory of Ultrasound Molecular Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China.
  • Wang J; Department of Ultrasound, Chongqing Key Laboratory of Ultrasound Molecular Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China.
  • Liu S; Department of Radiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China.
  • Cao Y; Department of Ultrasound, Chongqing Key Laboratory of Ultrasound Molecular Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China.
  • Li P; Department of Ultrasound, Chongqing Key Laboratory of Ultrasound Molecular Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China.
  • Wang Z; Department of Ultrasound, Chongqing Key Laboratory of Ultrasound Molecular Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China.
  • Ran H; Department of Ultrasound, Chongqing Key Laboratory of Ultrasound Molecular Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China.
  • Zhou Z; Department of General Practice of Chongqing General Hospital, University of Chinese Academy of Sciences, Chongqing, 401147, People's Republic of China. zzy16966@163.com.
  • Ren J; Department of Ultrasound, Chongqing Key Laboratory of Ultrasound Molecular Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China. renjianli@cqmu.edu.cn.
J Nanobiotechnology ; 19(1): 200, 2021 Jul 05.
Article em En | MEDLINE | ID: mdl-34225744

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Nanopartículas / Inibidores de Checkpoint Imunológico / Antineoplásicos Limite: Animals / Female / Humans Idioma: En Revista: J Nanobiotechnology Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Nanopartículas / Inibidores de Checkpoint Imunológico / Antineoplásicos Limite: Animals / Female / Humans Idioma: En Revista: J Nanobiotechnology Ano de publicação: 2021 Tipo de documento: Article